Geneva-based GeNeuro, a biopharmaceutical company, announced on Friday, February 2nd, that it successfully raised €5M in capital through ...
Vigneshwar Ravichandran
|
February 6, 2024
ExeVir Bio is a clinical stage biotechnology company developing nanobody based therapeutics focusing on infectious diseases.
Vishal Singh
January 9, 2023
New York-based alternative investment firm, Stonepeak, has announced a long-term partnership with Inspired Education Group. As part of ...
Editorial team
May 4, 2022
The COVID-19 pandemic brought numerous challenges for companies, creating radically different settings to operate. Businesses, both small and ...
December 10, 2021
At the TNW Conference 2021, the predominant theme was the “sense of normalcy”. After being forced to delay ...
October 6, 2021
Barcelona-based Seqera Labs has announced that it raised $5.5M(€4.6M) in a seed funding round
September 8, 2021
Vaccines and antibiotics continue to revolutionise our ability to prevent diseases, improve health and save lives. According to ...
August 9, 2021
COPAN, which stands for COllection and Preservation for ANalysis, was founded in 1979 in Mantua, Italy. This rebranding was a project that started for its 40th anniversary in 2019, but was postponed by the pandemic.
June 28, 2021
Baseimmune is a discovery-phase biotech startup that is focused on antigen discovery and vaccine development.
April 1, 2021
The financial world is in rapid development. Customers have different needs, products move online, companies turn digital. But ...
Dennis de Vries
Vaccitech is a clinical-stage biopharmaceutical company that is engaged in the discovery and development of two viral vector vaccines, one to prevent influenza and the other to treat prostate cancer.
March 22, 2021
While COVID-19 vaccination has started, gradual lifting of lockdown measures will still take some time. Even then, close monitoring of local outbreaks will remain an essential tool to avoid larger-scale lockdowns. A cautious approach will be needed to permit again events involving larger crowds.
Guest Contributor
February 11, 2021
01
02
03
04
05
More
[wp_dark_mode style="2"]
01
From port to startup fort: How Lars Crama is ‘Making it Happen’ in Rotterdam